MedImmune

Companies MedImmune

News MedImmune

• Evotec expands collaboration with MedImmune, receives milestone payment

  Evotec AG announced that it has expanded the scope of its collaboration with MedImmune after hitting a key milestone. Evotec achieved a milestone payment of EUR0.5 m. The milestone triggers a commercial license granted to MedImmune and an extension of the diabetes and beta cell regeneration collabor more

• Evotec announces metabolic disease alliance with MedImmune

  Evotec AG announced that via its subsidiary Develogen AG it has entered into a license and collaboration agreement with MedImmune (the global biologics unit of AstraZeneca), in the diabetes therapeutic area, with a particular focus on the regeneration of insulin producing beta cells. The license gi more

• arGEN-X appoints Dr Debbie Allen as Senior Director Business Development

  arGEN-X BV announced the appointment of Dr Debbie Allen as Senior Director Business Development. Dr Allen brings to arGEN-X more than 12 years of corporate and business development experience with small and large biotech companies. Dr Allen established her Business Development career at Cambridge A more

Publications MedImmune

• Understanding chronic inflammatory and neuropathic pain

  This meeting report highlights the main topics presented at the conference “Chronic Inflammatory and Neuropathic Pain,” convened jointly by the New York Academy of Sciences, MedImmune, and Grünenthal GmbH, on June 2–3, 2011, with the goal of providing a conducive environment for lively, informed, more

• Ligand Binding Assays in the 21st Century Laboratory: Automation

  Ligand Binding Assays in the 21st Century Laboratory: Automation Content Type Journal Article Category Commentary Pages 1-12 DOI 10.1208/s12248-012-9323-z Authors Ago B. Ahene, XOMA Corporation, 2710 Seventh Street, Berkeley, California 94710, USA Chris Morrow, Genentech, South San Fra more

• Patent watch

  Patent watch Nature Reviews Drug Discovery 10, 568 (2011). doi:10.1038/nrd3529 MedImmune's phage display patents invalidatedThe High Court of England and Wales has ruled that two patents (EP 0774511 and EP 2055777) owned by MedImmune that describe methods of phage display are i more

Market studies MedImmune

• World Influenza Vaccines Market 2011-2021

  Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and sale of influenza vaccines from 2009 to 2021. There, you will see commercial opportunities for influenza vaccines - original research, data and opini more

• World Biological Drugs Market 2011-2021

  Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide original research, data and opinions to benefit your work now. What revenues will biopharmaceutical markets achieve fro more

• Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review

  Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review Summary Novavax, Inc. (Novavax) is a biopharmaceutical company engaged in the discovery of new vaccines to treat a broad range of infectious diseases. The company develops drugs with the help of advanced proprietary virus-like par more

Websites MedImmune